+19-292-979-727
+44-203-287-6050

Network Point-of-Care Glucose Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Accu-Chek Inform II, StatStrip, HemoCue, BAROzen H Expert Plus, i-STAT, CareSens Expert Plus); By Region; Segment Forecast, 2021 - 2029

Published Date:Dec-2021
Pages: 101
Format: PDF
Report ID: PM2137
Base Year: 2020
Historical Data: 2017 - 2019

Report Summary

The global network point-of-care glucose testing market was valued at USD 1.27 billion in 2020 and is expected to grow at a CAGR of 4.0% during the forecast period. The demand for network point-of-care sugar testing is increasing owing to the growing demand of the homecare settings, along with bedside monitoring is propelling the market growth for network point-of-care sugar testing.

Know more about this report: request for sample pages

In addition, the evolving technological innovations for offering rapid, safe, and precise results for diagnostic tests further support the market development. Moreover, the rising prevalence of diabetes cases, lack of skilled diagnostic professionals is accelerating the adoption of the network point-of-care glucose testing, which, in turn, acts as a catalyzing factor for market growth for network point-of-care sugar testing over the projected period.

The widespread of coronavirus has affected every sector in the global economy. The network point-of-care glucose testing market is positively impacted on account of the growing incidences of diabetes, which, in turn, raises the mortality rate from COVID-19 patients. Accordingly, management of diabetes is a chief concern among healthcare specialists for decreasing the mortality rate. The rising responsiveness regarding poor healthcare access and lack of healthcare professionals is accelerating the global penetration of network point-of-care testing solutions. Therefore, the outbreak of COVID-19 brings an upsurge in demand for network point-of-care sugar testing and is likely to fuel the network point-of-care glucose testing market growth.

Network Point-of-Care Glucose Testing Market 2030

Know more about this report: request for sample pages

Industry Dynamics

Growth Drivers
The increasing prevalence of diabetes across the globe is leading to the network adoption of network point-of-care sugar testing, which accelerates market growth. These tests can effectively enhance the management of diseases, leading to the highest market penetration, especially in developing regions where the availability of timely medical care and the infrastructural facility is limited. Several physicians, patients, and health-aware citizens worldwide are using network point-of-care glucose testing accuracy for wellness and treatment of chronic diseases such as diabetes. According to the International Diabetic Federation (IDF), about 463 million adults between 20 and 79 had diabetes in 2019.

Moreover, data is expected to rise to almost 700 million patients by 2045. Therefore, increasing prevalence rates of diabetes and the changes in lifestyle and eating habits of the people are the prime factors responsible for the global market growth. Accordingly, the novel concept of network point-of-care sugar testing is significant for diabetes because it actively monitors the disease and tracks the sugar level in the blood in the patient. Furthermore, these devices provide a quick report and other medical circumstances data associated with patients to the healthcare professionals. Thus, an extensive collection of data facilitates healthcare services to present effective treatment to each patient. Hence, in turn, it is likely to strengthen the adoption of network point-of-care glucose testing for diabetes treatment worldwide.

Report Segmentation

The market is primarily segmented on the basis of product and region.

By Product	By Region
i-STAT Accu-Chek Inform II StatStrip HemoCue CareSens Expert Plus BAROzen H Expert Plus	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Russia, Netherlands) Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report: request for sample pages

Insight by Product

The Accu-Chek Inform II segment is the leading segment in terms of revenue generation in the year 2020 and is expected to dominate the market in approaching years. The Accu-Chek Inform II glucose meter is intended for in-vitro diagnostic functions, which helps identify blood sugar levels in the patient’s body. The point of care glucose testing meters scrutinizes blood sugar levels in neonatal, venous, arterial, and capillary, along with overall blood samples. It is a home-based self-monitoring device that assists patients in carrying out their regular activities with ease; hence it also presents immediate results of patient blood glucose levels.

Healthcare specialists prefer Accu-Chek Inform II because it provides a bedside system that facilitates the determination of glucose and automates managing the information produced by blood glucose tests. Besides, it is also a home-based self-monitoring device that assists patients in carrying out their regular activities with ease; hence it also presents immediate results of patient blood glucose levels. Thus, the growing adoption of these devices by the professionals and the general population, which in turn, lead to the dominance of the segment.

The i-STAT segment is estimated to show the highest growth in the network point-of-care glucose testing industry over the projected period. I-STAT is an in vitro whole-blood analyzer adopted for the sole-use cartridges for significant care tests at the point-of-care like in the metabolites, coagulation, electrolytes, and blood gases. A blood analysis system presents the most extensive menu of tests on a single, lightweight, and portable point-of-care platform that offers diagnostic information to healthcare professionals. This device is equipped with testing cartridges for observing various sets of analytes that eradicate the requirement for numerous analyzers for different analytes. Hence, these factors act as a catalyzing factor for the segment growth in the network point-of-care glucose testing industry over the coming years.

Geographic Overview

North America is the most significant revenue contributor in 2020 and is expected to dominate the global market for network point-of-care glucose testing over the forecast period. The presence of the highest number of leading manufacturers such as Prodigy Diabetes Care, LLC, Nova Biomedical, and Abbott are majorly acting as catalyzing factors for the market development of network PoC glucose testing.

Growing adoption of the PoC glucose testing for personal and professional usage may further lead to the dominance of the market. Besides, increasing investment in the government on the management of the diabetes segment and the availability of favorable reimbursement policies, which helps in the rapid penetration of developed devices, boosts the market growth for network point-of-care glucose testing. Moreover, Europe is projected to grow at the highest CAGR globally in the coming years due to rapid CE approvals and the development of the regional healthcare market.

In addition, the rising prevalence of diabetes and other lifestyle diseases, the growing need for quick diagnostic tools for diabetes management, and the robust existence of local market players are attributed to the market growth for network point-of-care glucose testing. Furthermore, increasing market demand for miniaturized & portable models and rising responsiveness for the adoption of network point-of-care glucose testing are expected to drive market demand.

Competitive Insight

Some of the major players operating in the global market for network point-of-care glucose testing include F. Hoffmann-La Roche Ltd., Bayer AG/Ascensia Diabetes Care Holdings AG, Nova Biomedical, Abbott, LLC (Lifescan, Inc.), and Danaher.

Network Point-of-Care Glucose Testing Market Report Scope

Report Attributes	Details
Market size value in 2020	USD 1.27 billion
Revenue forecast in 2029	USD 1.79 billion
CAGR	4.0% from 2021 - 2029
Base year	2020
Historical data	2017 - 2019
Forecast period	2021 - 2029
Quantitative units	Revenue in USD million/billion and CAGR from 2021 to 2029
Segments covered	By Product, By Region
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies	F. Hoffmann-La Roche Ltd., Bayer AG/Ascensia Diabetes Care Holdings AG, Nova Biomedical, Abbott, LLC (Lifescan, Inc.), and Danaher.

Introduction
1. Report Description
  1. Objectives of the Study
  2. Market Scope
  3. Assumptions
2. Stakeholders
Executive Summary
1. Market Highlights
Research Methodology
1. Overview
  1. Data Mining
2. Data Sources
  1. Primary Sources
  2. Secondary Sources
Global Network Point-of-Care Glucose Testing Market Insights
1. Network Point-of-Care Glucose Testing – Industry Snapshot
2. Network Point-of-Care Glucose Testing Market Dynamics
  1. Drivers and Opportunities
  2. Restraints and Challenges
3. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers (Moderate)
  2. Threats of New Entrants: (Low)
  3. Bargaining Power of Buyers (Moderate)
  4. Threat of Substitute (Moderate)
  5. Rivalry among existing firms (High)
4. PESTEL Analysis
5. Network Point-of-Care Glucose Testing Market Industry Trends
6. Value Chain Analysis
7. COVID-19 Impact Analysis
Global Network Point-of-Care Glucose Testing Market, by Product
1. Key Findings
2. Introduction
  1. Global Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
3. i-STAT
  1. Global Network Point-of-Care Glucose Testing Market, by i-STAT, by Region, 2017 - 2029 (USD Million)
4. Accu-Chek Inform II
  1. Global Network Point-of-Care Glucose Testing Market, by Accu-Chek Inform II, by Region, 2017 - 2029 (USD Million)
5. StatStrip
  1. Global Network Point-of-Care Glucose Testing Market, by StatStrip, by Region, 2017 - 2029 (USD Million)
6. HemoCue
  1. Global Network Point-of-Care Glucose Testing Market, by HemoCue, by Region, 2017 - 2029 (USD Million)
7. CareSens Expert Plus
  1. Global Network Point-of-Care Glucose Testing Market, by CareSens Expert Plus, by Region, 2017 - 2029 (USD Million)
8. BAROzen H Expert Plus
  1. Global Network Point-of-Care Glucose Testing Market, by BAROzen H Expert Plus, by Region, 2017 - 2029 (USD Million)
Global Network Point-of-Care Glucose Testing Market, by Geography
1. Key findings
2. Introduction
  1. Network Point-of-Care Glucose Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
3. Network Point-of-Care Glucose Testing Market – North America
  1. North America: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  2. Network Point-of-Care Glucose Testing Market – U.S.
    1. U.S.: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  3. Network Point-of-Care Glucose Testing Market – Canada
    1. Canada: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
4. Network Point-of-Care Glucose Testing Market – Europe
  1. Europe: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  2. Network Point-of-Care Glucose Testing Market – UK
    1. UK: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  3. Network Point-of-Care Glucose Testing Market – France
    1. France: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  4. Network Point-of-Care Glucose Testing Market – Germany
    1. Germany: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  5. Network Point-of-Care Glucose Testing Market – Italy
    1. Italy: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  6. Network Point-of-Care Glucose Testing Market – Spain
    1. Spain: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  7. Network Point-of-Care Glucose Testing Market – Netherlands
    1. Netherlands: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  8. Network Point-of-Care Glucose Testing Market – Russia
    1. Russia: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
5. Network Point-of-Care Glucose Testing Market – Asia Pacific
  1. Asia Pacific: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  2. Network Point-of-Care Glucose Testing Market – China
    1. China: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  3. Network Point-of-Care Glucose Testing Market – India
    1. India: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  4. Network Point-of-Care Glucose Testing Market – Malaysia
    1. Malaysia: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  5. Network Point-of-Care Glucose Testing Market – Japan
    1. Japan: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  6. Network Point-of-Care Glucose Testing Market – Indonesia
    1. Indonesia: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  7. Network Point-of-Care Glucose Testing Market – South Korea
    1. South Korea: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
6. Network Point-of-Care Glucose Testing Market – Middle East & Africa
  1. Middle East & Africa: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  2. Network Point-of-Care Glucose Testing Market – Saudi Arabia
    1. Saudi Arabia: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  3. Network Point-of-Care Glucose Testing Market – UAE
    1. UAE: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  4. Network Point-of-Care Glucose Testing Market – Israel
    1. Israel: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  5. Network Point-of-Care Glucose Testing Market – South Africa
    1. South Africa: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
7. Network Point-of-Care Glucose Testing Market – Latin America
  1. Latin America: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  2. Network Point-of-Care Glucose Testing Market – Mexico
    1. Mexico: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  3. Network Point-of-Care Glucose Testing Market – Brazil
    1. Brazil: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
  4. Network Point-of-Care Glucose Testing Market – Argentina
    1. Argentina: Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Competitive Landscape
1. Expansion and Acquisition Analysis
  1. Expansion
  2. Acquisitions
2. Partnerships/Collaborations/Agreements/Exhibitions
Company Profiles
1. F. Hoffmann-La Roche Ltd.
  1. Company Overview
  2. Financial Performance
  3. Product Benchmarking
  4. Recent Development
2. Bayer AG/Ascensia Diabetes Care Holdings AG
  1. Company Overview
  2. Financial Performance
  3. Product Benchmarking
  4. Recent Development
3. Nova Biomedical
  1. Company Overview
  2. Financial Performance
  3. Product Benchmarking
  4. Recent Development
4. Abbott, LLC (Lifescan, Inc.)
  1. Company Overview
  2. Financial Performance
  3. Product Benchmarking
  4. Recent Development
5. Danaher Corporation
  1. Company Overview
  2. Financial Performance
  3. Product Benchmarking
  4. Recent Development

List of Tables

Table 1 Global Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 2 Network Point-of-Care Glucose Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
Table 3 North America Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 4 U.S. Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 5 Canada Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 6 Europe Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 7 France Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 8 Germany Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 9 Italy Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 10 Spain Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 11 UK Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 12 Russia Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 13 Netherlands Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 14 Asia Pacific Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 15 China Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 16 India Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 17 Indonesia Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 18 Malaysia Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 19 Japan Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 20 South Korea Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 21 Latin America Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 22 Argentina Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 23 Brazil Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 24 Mexico Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 25 Middle East & Africa Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 26 Israel Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 27 Saudi Arabia Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 28 South Africa Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)
Table 29 UAE Network Point-of-Care Glucose Testing Market, by Product, 2017 - 2029 (USD Million)

List of Figures

Figure 1. Global Network Point-of-Care Glucose Testing Market, 2017 - 2029 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Product
Figure 7. Global Network Point-of-Care Glucose Testing Market, by Product, 2020 & 2029 (USD Million)
Figure 8. Network Point-of-Care Glucose Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
Figure 9. Strategic Analysis – Network Point-of-Care Glucose Testing Market

Report Scope

Network Point-of-Care Glucose Testing Market, Product Outlook (Revenue, USD Million, 2017 - 2029)

i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus

Network Point-of-Care Glucose Testing Market, Regional Outlook (Revenue, USD Million, 2017 - 2029)

North America
- Product Outlook
  - i-STAT
  - Accu-Chek Inform II
  - StatStrip
  - HemoCue
  - CareSens Expert Plus
  - BAROzen H Expert Plus
Europe
- Product Outlook
  - i-STAT
  - Accu-Chek Inform II
  - StatStrip
  - HemoCue
  - CareSens Expert Plus
  - BAROzen H Expert Plus
Asia Pacific
- Product Outlook
  - i-STAT
  - Accu-Chek Inform II
  - StatStrip
  - HemoCue
  - CareSens Expert Plus
  - BAROzen H Expert Plus
Latin America
- Product Outlook
  - i-STAT
  - Accu-Chek Inform II
  - StatStrip
  - HemoCue
  - CareSens Expert Plus
  - BAROzen H Expert Plus
Middle East & Africa
- Product Outlook
  - i-STAT
  - Accu-Chek Inform II
  - StatStrip
  - HemoCue
  - CareSens Expert Plus
  - BAROzen H Expert Plus

Qualitative Analysis

Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL Analysis
- Value Chain Analysis
- Key market opportunities prioritized
Competitive landscape
- Overview
- Financials
- Product benchmarking
- Latest strategic developments
- Price Trend Analysis

Quantitative Analysis

Market size, estimates, and forecasts from 2017 - 2029
Market size and revenue estimates for product up to 2029
Regional market size and forecast up to 2029
Company financials

Research Methodology | Research Techniques of Polaris Market Research

Request for Sample

Please fill out the form to receive sample pages of the report.

By using this form you agree with the storage and handling of your data by this website.

License and Pricing

Single User - $ 4250

Multi Users (Up to 20 User) - $ 5250

Enterprise License - $ 6250

Purchase Report Sections

Regional analysis
Segmentation analysis
Industry outlook
Competitive landscape

Request for Discount Pricing

Connect with experts

Speak to Analyst Request for Customization

Network Point-of-Care Glucose Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Accu-Chek Inform II, StatStrip, HemoCue, BAROzen H Expert Plus, i-STAT, CareSens Expert Plus); By Region; Segment Forecast, 2021 - 2029

Report Summary

Industry Dynamics

Report Segmentation

Insight by Product

Geographic Overview

Competitive Insight

Network Point-of-Care Glucose Testing Market Report Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Report Scope

Report Scope

Qualitative Analysis

Quantitative Analysis

Research Methodology | Research Techniques of Polaris Market Research

Request for Sample

License and Pricing

Purchase Report Sections

Connect with experts

Suggested Report